|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Nuclear protein
|
 |
|
Title:
|
 |
Structural and biochemical basis for the binding selectivity of pparg to pgc-1a
|
|
Structure:
|
 |
Peroxisome proliferator-activated receptor gamma. Chain: a. Fragment: lbd domain (unp residues 234-504). Synonym: ppar-gamma, nuclear receptor subfamily 1 group c member 3. Engineered: yes. Pgc-1alfa peptide. Chain: b. Synonym: ppar-gamma coactivator 1-alpha, ppargc-1-alpha, pgc-1-alpha, ligand effect modulator 6.
|
|
Source:
|
 |
Homo sapiens. Gene: ppargc1a, lem6, pgc1, pgc1a, ppargc1. Expressed in: escherichia coli. Synthetic: yes. Other_details: the peptide is chemically synthesized. It is found naturally in humans
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.227
|
R-free:
|
0.282
|
|
|
Authors:
|
 |
Y.Li,D.Martynowski
|
Key ref:
|
 |
Y.Li
et al.
(2008).
Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor gamma to PGC-1alpha.
J Biol Chem,
283,
19132-19139.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Apr-08
|
Release date:
|
03-Jun-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
283:19132-19139
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor gamma to PGC-1alpha.
|
|
Y.Li,
A.Kovach,
K.Suino-Powell,
D.Martynowski,
H.E.Xu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The functional interaction between the peroxisome proliferator-activated
receptor gamma (PPARgamma) and its coactivator PGC-1alpha is crucial for the
normal physiology of PPARgamma and its pharmacological response to antidiabetic
treatment with rosiglitazone. Here we report the crystal structure of the
PPARgamma ligand-binding domain bound to rosiglitazone and to a large PGC-1alpha
fragment that contains two LXXLL-related motifs. The structure reveals critical
contacts mediated through the first LXXLL motif of PGC-1alpha and the PPARgamma
coactivator binding site. Through a combination of biochemical and structural
studies, we demonstrate that the first LXXLL motif is the most potent among all
nuclear receptor coactivator motifs tested, and only this motif of the two
LXXLL-related motifs in PGC-1alpha is capable of binding to PPARgamma. Our
studies reveal that the strong interaction of PGC-1alpha and PPARgamma is
mediated through both hydrophobic and specific polar interactions. Mutations
within the context of the full-length PGC-1alpha indicate that the first
PGC-1alpha motif is necessary and sufficient for PGC-1alpha to coactivate
PPARgamma in the presence or absence of rosiglitazone. These results provide a
molecular basis for specific recruitment and functional interplay between
PPARgamma and PGC-1alpha in glucose homeostasis and adipocyte differentiation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
FIGURE 3. Purification and crystallization of the PPAR LBD
complexed with a PGC-1 fragment. A, a
schematic representation showing the PGC-1 protein and its two
receptor-interacting motifs (ID1 and ID2). The PGC-1 fragment
(101-220) that includes both ID1 and ID2 motifs was used in
cocrystallization with PPAR . B, purification of
the PPAR LBD and PGC-1 complex.
The proteins of PPAR and PGC-1 were
purified separately and complexed using excess PGC-1 in the
presence of rosiglitazone. The PPAR ·PGC-1 complex
and PGC-1 alone were separated by
gel filtration. The complex was eluted in the first peak and
collected and concentrated to 10 mg/ml for the crystallization
trial. C, the protein complex samples shown on an SDS gel. The
molecular mass markers are shown in the KD lane (kilodaltons).
Lanes 1-9 are fractions from the gel filtration column
corresponding to the two peaks in B, from left to right. D,
crystals of the PPAR ·rosiglitazone·PGC-1
complex.
|
 |
Figure 6.
FIGURE 6. Molecular determinants of the PGC-1 /PPAR
interactions. A and B,
the docking mode of PGC-1 ID1 (yellow) on the
surface of PPAR (coactivator binding
site) is shown. The hydrophobic interaction is shown in A, and
the specific intermolecular interaction is shown in B. C and D,
the binding interface of PGC-1 /PPAR shows
the specific intermolecular and intramolecular interactions. The
PGC-1 is shown in green, the
PPAR is in red, and the
hydrogen bonds are shown as arrows.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2008,
283,
19132-19139)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Li,
A.Dai,
R.Hu,
L.Zhu,
and
S.Tan
(2010).
Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease.
|
| |
Acta Biochim Biophys Sin (Shanghai),
42,
603-614.
|
 |
|
|
|
|
 |
L.Jin,
and
Y.Li
(2010).
Structural and functional insights into nuclear receptor signaling.
|
| |
Adv Drug Deliv Rev,
62,
1218-1226.
|
 |
|
|
|
|
 |
N.Viswakarma,
Y.Jia,
L.Bai,
A.Vluggens,
J.Borensztajn,
J.Xu,
and
J.K.Reddy
(2010).
Coactivators in PPAR-Regulated Gene Expression.
|
| |
PPAR Res,
2010,
0.
|
 |
|
|
|
|
 |
S.N.Lewis,
J.Bassaganya-Riera,
and
D.R.Bevan
(2010).
Virtual Screening as a Technique for PPAR Modulator Discovery.
|
| |
PPAR Res,
2010,
861238.
|
 |
|
|
|
|
 |
X.E.Zhou,
K.M.Suino-Powell,
J.Li,
Y.He,
J.P.Mackeigan,
K.Melcher,
E.L.Yong,
and
H.E.Xu
(2010).
Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor.
|
| |
J Biol Chem,
285,
9161-9171.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.E.Zhou,
K.Suino-Powell,
P.L.Ludidi,
D.P.McDonnell,
and
H.E.Xu
(2010).
Expression, purification and primary crystallographic study of human androgen receptor in complex with DNA and coactivator motifs.
|
| |
Protein Expr Purif,
71,
21-27.
|
 |
|
|
|
|
 |
G.B.Rha,
G.Wu,
S.E.Shoelson,
and
Y.I.Chi
(2009).
Multiple binding modes between HNF4alpha and the LXXLL motifs of PGC-1alpha lead to full activation.
|
| |
J Biol Chem,
284,
35165-35176.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Melcher,
L.M.Ng,
X.E.Zhou,
F.F.Soon,
Y.Xu,
K.M.Suino-Powell,
S.Y.Park,
J.J.Weiner,
H.Fujii,
V.Chinnusamy,
A.Kovach,
J.Li,
Y.Wang,
J.Li,
F.C.Peterson,
D.R.Jensen,
E.L.Yong,
B.F.Volkman,
S.R.Cutler,
J.K.Zhu,
and
H.E.Xu
(2009).
A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors.
|
| |
Nature,
462,
602-608.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |